A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in atrial fibrillation
, , , , y
23 ago 2022
Acerca de este artículo
Publicado en línea: 23 ago 2022
Páginas: 91 - 101
Recibido: 14 abr 2022
Aceptado: 04 jun 2022
DOI: https://doi.org/10.2478/acm-2022-0011
Palabras clave
© 2022 Raghu K. et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Raghu, K
Department of Emergency Medicine, Narayana Medical College and HospitalNellore, India
Ramakrishnan, TV
Emergency Department, Sri Ramachandra Medical College and Research InstituteChennai, India
Sreedevi, G
Emergency Department, Sri Ramachandra Medical College and Research InstituteChennai, India
Shreevani, P
Department of Emergency Medicine, Narayana Medical College and HospitalNellore, India
Gopala Krishna, S
Department of Emergency Medicine, Narayana Medical College and HospitalNellore, India
Ravishankar, B
Department of Emergency Medicine, Narayana Medical College and HospitalNellore, India